MetaVia is trading up 5.13% in after-hours trading at $1.23, compared with its November 2 regular-session close of $1.17; no confirmed company-specific announcement explains the move.
- Recent coverage reported that MetaVia was adjusting payment timing on about $700,000 owed to Dong-A ST, a potentially adverse financial development.
- A previously announced clinical-data presentation is scheduled for November 4, but available evidence does not establish that it drove the gain.